92
Views
0
CrossRef citations to date
0
Altmetric
Reflections and scientific reviews from established women scientists

Flying rats and microbeam paths crossing: the beauty of international interdisciplinary science

ORCID Icon
Pages 466-473 | Received 03 Nov 2021, Accepted 22 Dec 2021, Published online: 07 Jan 2022

References

  • Bouchet A, Boumendjel A, Khalil E, Serduc R, Bräuer E, Siegbahn EA, Laissue JA, Boutonnat J. 2012. Chalcone JAI-51 improves efficacy of synchrotron microbeam radiation therapy of brain tumors. J Synchrotron Rad. 19(4):478–482.
  • Bouchet A, Lemasson B, Christen T, Potez M, Rome C, Coquery N, Le Clec’h C, Moisan A, Bräuer-Krisch E, Leduc G, et al. 2013. Synchrotron microbeam radiation therapy induces hypoxia in intracerebral gliosarcoma but not in the normal brain. Radiother Oncol. 108(1):143–148.
  • Bouchet A, Lemasson B, Le Duc G, Maisin C, Bräuer-Krisch E, Siegbahn EA, Renaud L, Khalil E, Rémy C, Poillot C, et al. 2010. Preferential effect of synchrotron microbeam radiation therapy on intracerebral 9L gliosarcoma vascular networks. Int J Radiat Oncol Biol Phys. 78(5):1503–1512.
  • Bouchet A, Potez M, Coquery N, Rome C, Lemasson B, Bräuer-Krisch E, Rémy C, Laissue J, Barbier EL, Djonov V, et al. 2017. Permeability of Brain Tumor Vessels Induced by Uniform or Spatially Microfractionated Synchrotron Radiation Therapies. Int J Radiat Oncol Biol Phys. 98(5):1174–1182.
  • Bouchet A, Sakakini N, Atifi ME, Le Clec'h C, Bräuer-Krisch E, Rogalev L, Laissue JA, Rihet P, Le Duc G, Pelletier L. 2015. Identification of AREG and PLK1 pathway modulation as a potential key of the response of intracranial 9L tumor to microbeam radiation therapy. Int J Cancer. 136(11):2705–2716.
  • Bouchet A, Sakakini N, El Atifi M, Le Clec'h C, Brauer E, Moisan A, Deman P, Rihet P, Le Duc G, Pelletier L. 2013. Early gene expression analysis in 9L orthotopic tumor-bearing rats identifies immune modulation in molecular response to synchrotron microbeam radiation therapy. PLoS One. 8(12):e81874.
  • Bouchet A, Serduc R, Laissue JA, Djonov V. 2015. Effects of microbeam radiation therapy on normal and tumoral blood vessels. Phys Med. 31(6):634–641.
  • Bräuer-Krisch E, Requardt H, Brochard T, Berruyer G, Renier M, Laissue JA, Bravin A. 2009. New technology enables high precision multislit collimators for microbeam radiation therapy. Rev Sci Instrum. 80(7):074301.
  • Bräuer-Krisch E, Requardt H, Régnard P, Corde S, Siegbahn E, LeDuc G, Brochard T, Blattmann H, Laissue J, Bravin A. 2005. New irradiation geometry for microbeam radiation therapy. Phys Med Biol. 50(13):3103–3111.
  • Butler DJ, Beveridge T, Lehmann J, Oliver CP, Stevenson AW, Livingstone J. 2018. Spatial response of synthetic microDiamond and diode detectors measured with kilovoltage synchrotron radiation. Med Phys. 45(2):943–952.
  • Donzelli M, Oelfke U, Bräuer-Krisch E. 2019. Introducing the concept of spiral microbeam radiation therapy (spiralMRT). Phys Med Biol. 64(6):065005.
  • Bräuer-Krisch E, Bravin A, Zhang L, Siegbahn E, Stepanek J, Blattmann H, Slatkin DN, Gebbers J-O, Jasmin M, Laissue JA. 2005. Characterization of a tungsten/gas multislit collimator for microbeam radiation therapy at the European Synchrotron Radiation Facility. Rev Sci Inst. 76(6):064303.
  • Engels E, Li N, Davis J, Paino J, Cameron M, Dipuglia A, Vogel S, Valceski M, Khochaiche A, O’Keefe A, et al. 2020. Toward personalized synchrotron microbeam radiation therapy. Sci Rep. 2020 10(1):8833.
  • Falzon G, Pearson S, Murison R, Hall C, Siu K, Round A, Schültke E, Kaye AH, Lewis R. 2007. Myelin structure is a key difference in the x-ray scattering signature between meningioma, schwannoma and glioblastoma multiforme. Phys Med Biol. 52(21):6543–6553.
  • Fernandez-Palomo C, Bräuer-Krisch E, Laissue J, Vukmirovic D, Blattmann H, Seymour C, Schültke E, Mothersill C. 2015. Use of synchrotron medical microbeam irradiation to investigate radiation-induced bystander and abscopal effects in vivo. Phys Med. 31(6):584–595.
  • Fernandez-Palomo C, Mothersill C, Bräuer-Krisch E, Laissue J, Seymour C, Schültke E. 2015. γ-H2AX as a marker for dose deposition in the brain of wistar rats after synchrotron microbeam radiation. PLoS One. 10(3):e0119924.
  • Fernandez-Palomo C, Schültke E, Smith R, Bräuer-Krisch E, Laissue J, Schroll C, Fazzari J, Seymour C, Mothersill C. 2013. Bystander effects in tumor-free and tumor-bearing rat brains following irradiation by synchrotron X-rays. Int J Radiat Biol. 89(6):445–453.
  • Forrester HB, Lobachevsky PN, Stevenson AW, Hall CJ, Martin OA, Sprung CN. 2020. Abscopal Gene Expression in Response to Synchrotron Radiation Indicates a Role for Immunological and DNA Damage Response Genes. Radiat Res. 194(6):678–687.
  • Fournier P, Cornelius I, Donzelli M, Requardt H, Nemoz C, Petasecca M, Bräuer-Krisch E, Rosenfeld A, Lerch M. 2016. X-Tream quality assurance in synchrotron X-ray microbeam radiation therapy. J Synchrotron Radiat. 23(Pt 5):1180–1190. 2016 Sep 1
  • Fournier P, Crosbie JC, Cornelius I, Berkvens P, Donzelli M, Clavel AH, Rosenfeld AB, Petasecca M, Lerch ML, Bräuer-Krisch E. 2016. Absorbed dose-to-water protocol applied to synchrotron-generated x-rays at very high dose rates. Phys Med Biol. 61(14):N349–61.
  • Grotzer MA, Schültke E, Bräuer-Krisch E, Laissue JA. 2015. Microbeam radiation therapy: Clinical perspectives. Phys Med. 31(6):564–567.
  • Herrault A, Le Duc G, Picard L, Liot S. 2013. Grenoblicimes. Glénat.
  • Kelly ME, Schültke E, Fiedler S, Nemoz C, Guzman R, Corde S, Esteve F, LeDuc G, Juurlink BHJ, Meguro K. 2007. Synchrotron-based intravenous cerebral angiography in a small animal model. Phys Med Biol. 52(4):1001–1012.
  • Laissue JA. 2021. Elke Bräuer-Krisch: dedication, creativity and generosity: May 17, 1961-September 10, 2018. Int J Radiat Biol. 1:1–8.
  • Laissue JA, Blattmann H, Wagner HP, Grotzer MA, Slatkin DN. 2007. Prospects for microbeam radiation therapy of brain tumours in children to reduce neurological sequelae. Dev Med Child Neurol. 49(8):577–581.
  • Laissue JA, Geiser G, Spanne PO, Dilmanian FA, Gebbers JO, Geiser M, Wu XY, Makar MS, Micca PL, Nawrocky MM, et al. 1998. Neuropathology of ablation of rat gliosarcomas and contiguous brain tissues using a microplanar beam of synchrotron-wiggler-generated X rays. Int J Cancer. 78(5):654–660.
  • Le Duc G, Miladi I, Alric C, Mowat P, Bräuer-Krisch E, Bouchet A, Khalil E, Billotey C, Janier M, Lux F, et al. 2011. Toward an image-guided microbeam radiation therapy using gadolinium-based nanoparticles. ACS Nano. 5(12):9566–9574.
  • Le Duc G, Roux S, Paruta-Tuarez A, Dufort S, Brauer E, Marais A, Truillet C, Sancey L, Perriat P, Lux F, et al. 2014. Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment. Cancer Nano. 5(1):4.
  • Livingstone J, Adam JF, Crosbie JC, Hall CJ, Lye JE, McKinlay J, Pelliccia D, Pouzoulet F, Prezado Y, Stevenson AW, et al. 2017. Preclinical radiotherapy at the Australian Synchrotron's Imaging and Medical Beamline: instrumentation, dosimetry and a small-animal feasibility study. J Synchrotron Rad. 24(4):854–865.
  • Livingstone J, Stevenson AW, Butler DJ, Häusermann D, Adam JF. 2016. Characterization of a synthetic single crystal diamond detector for dosimetry in spatially fractionated synchrotron x-ray fields. Med Phys. 43(7):4283.
  • Livingstone J, Stevenson AW, Häusermann D, Adam JF. 2018. Experimental optimisation of the X-ray energy in microbeam radiation therapy. Phys Med. 45:156–161.
  • Lobachevsky P, Forrester HB, Ivashkevich A, Mason J, Stevenson AW, Hall CJ, Sprung CN, Djonov VG, Martin OA. 2021. Synchrotron X-Ray Radiation-Induced Bystander Effect: An Impact of the Scattered Radiation, Distance From the Irradiated Site and p53 Cell Status. Front Oncol. 11:685598.
  • Lobachevsky P, Ivashkevich A, Forrester HB, Stevenson AW, Hall CJ, Sprung CN, Martin OA. 2015. Assessment and Implications of Scattered Microbeam and Broadbeam Synchrotron Radiation for Bystander Effect Studies. Radiat Res. 184(6):650–659.
  • Lobachevsky PN, Ventura J, Giannakandropoulou L, Forrester H, Palazzolo JS, Haynes NM, Stevenson AW, Hall CJ, Mason J, Pollakis G, et al. 2019. A Functional Immune System Is Required for the Systemic Genotoxic Effects of Localized Irradiation. Int J Radiat Oncol Biol Phys. 103(5):1184–1193.
  • Mannan KA, Arfelli F, Beveridge T, Butler S, Chapman D, Gillam J, Hall C, Juurlink B, Kelly K, Kelly M, et al. 2005. Synchrotron Supported DEI and Small Angle Scattering (SAXS) Analysis of Brain Tumor in an Animal Model. NIMA. 548(1-2):169–174.
  • Martínez-Rovira I, Prezado Y. 2014. Minibeam radiation therapy for the management of osteosarcomas: a Monte Carlo study. Med Phys. 41(6):061706.
  • Martínez-Rovira I, Sempau J, Prezado Y. 2014. Monte Carlo-based dose calculation engine for minibeam radiation therapy. Phys Med. 30(1):57–62.
  • Mothersill C, Fernandez-Palomo C, Fazzari J, Smith R, Schültke E, Bräuer-Krisch E, Laissue J, Schroll C, Seymour C. 2014. Transmission of signals from rats receiving high doses of microbeam radiation to cage mates: an inter-mammal bystander effect. Dose Response. 12(1):72–92.
  • Nettelbeck H, Takacs GJ, Lerch ML, Rosenfeld AB. 2009. Microbeam radiation therapy: a Monte Carlo study of the influence of the source, multislit collimator, and beam divergence on microbeams. Med Phys. 36(2):447–456.
  • Ohno Y, Torikoshi M, Suzuki M, Umetani K, Imai Y, Uesugi K, Yagi N. 2008. Dose distribution of a 125 keV mean energy microplanar x-ray beam for basic studies on microbeam radiotherapy. Med Phys. 35(7):3252–3258.
  • Pellicioli P, Donzelli M, Davis JA, Estève F, Hugtenburg R, Guatelli S, Petasecca M, Lerch MLF, Bräuer-Krisch E, Krisch M. 2021. Study of the X-ray radiation interaction with a multislit collimator for the creation of microbeams in radiation therapy. J Synchrotron Radiat. 28(Pt 2):392–403.
  • Posar JA, Large M, Alnaghy S, Paino JR, Butler DJ, Griffith MJ, Hood S, Lerch MLF, Rosenfeld A, Sellin PJ, et al. 2021. Towards high spatial resolution tissue-equivalent dosimetry for microbeam radiation therapy using organic semiconductors. J Synchrotron Radiat. 28(Pt 5):1444–1454.
  • Potez M, Bouchet A, Flaender M, Rome C, Collomb N, Grotzer M, Krisch M, Djonov V, Balosso J, Brun E, et al. 2020. Synchrotron X-Ray Boost Delivered by Microbeam Radiation Therapy After Conventional X-Ray Therapy Fractionated in Time Improves F98 Glioma Control. Int J Radiat Oncol Biol Phys. 107(2):360–369.
  • Potez M, Bouchet A, Wagner J, Donzelli M, Bräuer-Krisch E, Hopewell JW, Laissue J, Djonov V. 2018. Effects of synchrotron X-ray micro-beam irradiation on normal mouse ear pinnae. Int J Radiat Oncol Biol Phys. 101(3):680–689.
  • Potez M, Fernandez-Palomo C, Bouchet A, Trappetti V, Donzelli M, Krisch M, Laissue J, Volarevic V, Djonov V. 2019. Synchrotron microbeam radiation therapy as a new approach for the treatment of radioresistant melanoma: potential underlying mechanisms. Int J Radiat Oncol Biol Phys. 105(5):1126–1136.
  • Potez M, Trappetti V, Bouchet A, Fernandez-Palomo C, Güç E, Kilarski WW, Hlushchuk R, Laissue J, Djonov V. 2018. Characterization of a B16-F10 melanoma model locally implanted into the ear pinnae of C57BL/6 mice. PLoS One. 13(11):e0206693.
  • Prezado Y, Martinez-Rovira I, Thengumpallil S, Deman P. 2011. Dosimetry protocol for the preclinical trials in white-beam minibeam radiation therapy. Med Phys. 38(9):5012–5020.
  • Prezado Y, Renier M, Bravin A. 2009. A new method of creating minibeam patterns for synchrotron radiation therapy: a feasibility study. J Synchrotron Radiat. 16(Pt 4):582–586.
  • Prezado Y, Sarun S, Gil S, Deman P, Bouchet A, Le Duc G. 2012. Increase of lifespan for glioma-bearing rats by using minibeam radiation therapy. J Synchrotron Radiat. 19(Pt 1):60–65.
  • Prezado Y, Thengumpallil S, Renier M, Bravin A. 2009. X-ray energy optimization in minibeam radiation therapy. Med Phys. 36(11):4897–4902.
  • Régnard P, Bräuer-Krisch E, Troprès I, Keyriläinen J, Bravin A, Le Duc G. 2008. Enhancement of survival of 9L gliosarcoma bearing rats following intracerebral delivery of drugs in combination with microbeam radiation therapy. Eur J Radiol. 68(3 Suppl):S151–S5.
  • Rigley S, Rigon L, Ataelmannan K, Chapman D, Doucette R, Griebel R, Juurlink B, Arfelli F, Menk M, Tromba G, et al. 2005. Absorption edge subtraction imaging for volumetric measurement in an animal model of malignant brain tumor. Nuclear Inst. and Methods in Physics Research A. 548(1-2):88–93.
  • Schültke E, Bayat S, Bartzsch S, Bräuer-Krisch E, Djonov V, Fiedler S, Fernandez-Palomo C, Jaekel F, Pellicioli P, Trappetti V, et al. 2021. A Mouse Model for Microbeam Radiation Therapy of the Lung. Int J Radiat Oncol Biol Phys. 110(2):521–525.
  • Schültke E, Fiedler S, Menk RH, Jaekel F, Dreossi D, Casarin K, Tromba G, Bartzsch S, Kriesen S, Hildebrandt G, et al. 2021. Perspectives for microbeam irradiation at the SYRMEP beamline. J Synchrotron Radiat. 28(Pt 2):410–418.
  • Schültke E, Juurlink BH, Ataelmannan K, Laissue J, Blattmann H, Bräuer-Krisch E, Bravin A, Minczewska J, Crosbie J, Taherian H, et al. 2008. Memory and survival after microbeam radiation therapy. Eur J Radiol. 68(3 Suppl):S142–S6.
  • Serduc R, Bouchet A, Bräuer-Krisch E, Laissue JA, Spiga J, Sarun S, Bravin A, Fonta C, Renaud L, Boutonnat J, et al. 2009. Synchrotron microbeam radiation therapy for rat brain tumor palliation-influence of the microbeam width at constant valley dose. Phys Med Biol. 54(21):6711–6724.
  • Serduc R, Bräuer-Krisch E, Bouchet A, Renaud L, Brochard T, Bravin A, Laissue JA, Le Duc G. 2009. First trial of spatial and temporal fractionations of the delivered dose using synchrotron microbeam radiation therapy. J Synchrotron Rad. 16(4):587–590.
  • Siu KKW, Butler SM, Beveridge T, Gillam JE, Hall CJ, Kaye AH, Lewis RA, Mannan K, McLoughlin G, Pearson S, et al. 2005. Identifying markers of pathology in SAXS data of malignant tissues of the brain. NIMA. 548 (1-2):106–110.
  • Slatkin D, Dilmanian A, Spanne P. 1994. Method for microbeam radiation therapy, US Patent 53393473.
  • Smith R, Wang J, Seymour C, Fernandez-Palomo C, Fazzari J, Schültke E, Bräuer-Krisch E, Laissue J, Schroll C, Mothersill C. 2018. Homogenous and microbeam X-ray radiation induces proteomic changes in the brains of irradiated rats and in the brains of nonirradiated cage mate rats. Dose Response. 16(1):155932581775006.
  • Smith RW, Wang J, Schültke E, Seymour CB, Bräuer-Krisch E, Laissue JA, Blattmann H, Mothersill CE. 2013. Proteomic changes in the rat brain induced by homogenous irradiation and by the bystander effect resulting from high energy synchrotron X-ray microbeams. Int J Radiat Biol. 89(2):118–127.
  • Trappetti V, Fazzari JM, Fernandez-Palomo C, Scheidegger M, Volarevic V, Martin OA, Djonov VG. 2021. Microbeam Radiotherapy-A novel therapeutic approach to overcome radioresistance and enhance anti-tumour response in melanoma. IJMS. 22(14):7755.
  • Trappetti V, Fernandez-Palomo C, Smyth L, Klein M, Haberthür D, Butler D, Barnes M, Shintani N, de Veer M, Laissue JA, et al. 2021. Synchrotron microbeam radiation therapy for the treatment of lung carcinoma: a preclinical study. Int J Radiat Oncol Biol Phys. 111(5):1276–1288.
  • Ventura J, Lobachevsky PN, Palazzolo JS, Forrester H, Haynes NM, Ivashkevich A, Stevenson AW, Hall CJ, Ntargaras A, Kotsaris V, et al. 2017. Localized synchrotron irradiation of mouse skin induces persistent systemic genotoxic and immune responses. Cancer Res. 77(22):6389–6399.
  • Ventura JA, Donoghue JF, Nowell CJ, Cann LM, Day LRJ, Smyth LML, Forrester HB, Rogers PAW, Crosbie JC. 2021. The γH2AX DSB marker may not be a suitable biodosimeter to measure the biological MRT valley dose. Int J Radiat Biol. 97(5):642–656.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.